Related Experiment Videos

[The Communauté française' eradication plan for measles, mumps and rubella]

Archives Belges = Belgisch Archief
|January 1, 1989
PubMed

Insights

The measles, mumps, and rubella (MMR) vaccine is crucial for disease elimination. A new program in Belgium aims to boost MMR vaccine coverage, which is currently at 60% for young children.

Area of Science:

  • Public Health
  • Vaccinology
  • Epidemiology

Context:

  • The measles, mumps, and rubella (MMR) vaccine has been available in the French Community of Belgium since 1984 and part of the official immunization schedule since 1985.
  • Current MMR vaccination coverage in children under 24 months is estimated at 60%.

Purpose:

  • To improve the low MMR vaccination coverage rates in the French Community of Belgium.
  • To implement a comprehensive MMR immunization promotion program.

Summary:

  • The program involves a coordinated mobilization of various health structures, including Maternal and Child Health (MCH) organizations, school medicine, general practitioners, pediatricians, medical faculties, and health administration.
  • This initiative was proposed by the "Conseil Consultatif Communautaire de Prévention pour la Santé" and adopted by political authorities.

Impact:

  • The program aims to increase MMR vaccine uptake and contribute to the elimination of measles, mumps, and rubella.
  • Launched on February 1st, 1989, the program seeks to enhance community immunity against these preventable diseases.

Related Concept Videos